Viewing Study NCT04504734


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-01-01 @ 5:14 AM
Study NCT ID: NCT04504734
Status: TERMINATED
Last Update Posted: 2023-07-07
First Post: 2020-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bucillamine in Treatment of Patients With COVID-19
Sponsor: Revive Therapeutics, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module